Guggenheim analyst Seamus Fernandez initiated coverage of Vaxcyte with a Buy rating and $66 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PCVX:
Guggenheim analyst Seamus Fernandez initiated coverage of Vaxcyte with a Buy rating and $66 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PCVX: